Seoul, Republic of Korea
Title: Selective Retina therapy in Patients with Central Serous Chorioretinopathy
Biography: Kim Jooyeon
We evaluated visual outcomes, changes of central macular thickness in patients with central serous chorioretinopathy after treatment with selective retina therapy.
Seventeen eyes of sixteen patients who were diagnosed with central serous chorioretinopathy will incuded in the study. Location of laser was determined by fundus fluorescein angiography performed before laser treatment. OCT was conducted before laser treatment and 1 month after laser treatment to compare central macular thickness. Chart review were done including age, sex, best correct visual acuity, intraocular pressure, slit lamp examination, time of laser conducted after diagnosis, location of laser conducted, side effects.
Average best correct visual acuity at diagnosis and 1 month after laser treatment was 0.20(logMAR) and 0.12(logMAR) respectively, showing 0.08(logMAR) of best correct visual acuity improvement. Average central macular thickness decreased 176.92um from 213±46um at baseline to 36±20um at 1 month after selective retina therapy.
SRT of central serous chorioretinopathy patients showed favorable visual and structural outcomes without the risk of scotoma or other untreatable side effects.